Qyuns Therapeutics Co., Ltd. (HKG:2509)
Hong Kong · Delayed Price · Currency is HKD 15.08
-0.62 (-3.95%)
Jul 9, 2026, 4:08 PM HKT
Qyuns Therapeutics Market Cap
Qyuns Therapeutics has a market cap or net worth of 3.39 billion as of July 9, 2026. Its market cap has decreased by -3.73% in one year.
Market Cap
3.39B
Enterprise Value
2.86B
Revenue
897.99M
Ranking
n/a
PE Ratio
9.64
Stock Price
15.08
Market Cap Chart
Since March 20, 2024, Qyuns Therapeutics's market cap has decreased from 5.02B to 3.39B, a decrease of -32.49%. That is a compound annual growth rate of -15.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 3.39B | -20.05% |
| Dec 31, 2025 | 4.24B | 158.47% |
| Dec 31, 2024 | 1.64B | -67.33% |
| Mar 20, 2024 | 5.02B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TransThera Sciences (Nanjing) | 4.60B |
| Jacobio Pharmaceuticals Group | 4.07B |
| Ocumension Therapeutics | 4.02B |
| Guangzhou Innogen Pharmaceutical Group | 3.76B |
| Mirxes Holding Company | 3.66B |
| Shandong Boan Biotechnology | 3.22B |
| Laekna | 3.14B |
| Medtide | 3.14B |